Inducible nitric oxide synthase and PPARγ are involved in bladder cancer progression

Journal of Urology

Volumn 188, Issue 3, 2012, Pages 967-973

  Sandes, Eduardo Omar ^a   Lodillinsky, Catalina ^a   Langle, Yanina ^a   Belgorosky, Denise ^a   Marino, Lina ^a   Gimenez, Liliana ^a   Casabé, Alberto Ricardo ^a   Eiján, Ana María ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

disease progression; nitric oxide synthase type II; PPAR gamma; urinary bladder; urinary bladder neoplasms

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRITE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; UROTHELIUM; WESTERN BLOTTING;

ANIMALS; DISEASE PROGRESSION; HUMANS; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; PPAR GAMMA; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 84864947380     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.04.099     Document Type: Article

References (30)

1. A. Jemal, R. Siegel, E. Ward Cancer statistics, 2006 CA Cancer J Clin 56 2006 106
2. X.R. Wu Urothelial tumorigenesis: a tale of divergent pathways Nat Rev Cancer 5 2005 713
3. M.A. Knowles Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis 27 2006 361
4. R.G. Knowles, S. Moncada Nitric oxide synthases in mammals Biochem J 298 1994 249
5. S. Singh, A.K. Gupta Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies Cancer Chemother Pharmacol 67 2011 1211
6. F. Farinati, M. Piciocchi, E. Lavezzo Oxidative stress and inducible nitric oxide synthase induction in carcinogenesis Dig Dis 28 2010 579
7. A. Keibel, V. Singh, M.C. Sharma Inflammation, microenvironment, and the immune system in cancer progression Curr Pharm Des 15 2009 1949
8. E.O. Sandes, A.G. Faletti, M.D. Riveros Expression of inducible nitric oxide synthase in tumoral and non-tumoral epithelia from bladder cancer patients Nitric Oxide 12 2005 39
9. R.P. Brun, P. Tontonoz, B.M. Forman Differential activation of adipogenesis by multiple PPAR isoforms Genes Dev 10 1996 974
10. R.A. Daynes, D.C. Jones Emerging roles of PPARs in inflammation and immunity Nat Rev Immunol 2 2002 748
11. R. Kostadinova, W. Wahli, L. Michalik PPARs in diseases: control mechanisms of inflammation Curr Med Chem 12 2005 2995
12. Y. Guan, Y. Zhang, L. Davis Expression of peroxisome proliferator- activated receptors in urinary tract of rabbits and humans Am J Physiol 273 1997 F1013
13. S. Jain, S. Pulikuri, Y. Zhu Differential expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse Am J Pathol 153 1998 349
14. C.L. Varley, J. Stahlschmidt, W.C. Lee Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme J Cell Sci 117 2004 2029
15. Y.F. Guan, Y.H. Zhang, R.M. Breyer Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death Neoplasia 1 1999 330
16. K.I. Nakashiro, Y. Hayashi, A. Kita Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells Am J Pathol 159 2001 591
17. R. Yoshimura, M. Matsuyama, Y. Segawa Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists Int J Cancer 104 2003 597
18. L. Possati, R. Rocchetti, S. Talevi The role of peroxisome proliferator-activated receptor gamma in bladder cancer in relation to angiogenesis and progression Gen Pharmacol 35 2000 269
19. S.H. Tannehill-Gregg, T.P. Sanderson, D. Minnema Rodent carcinogenicity profile of the antidiabetic dual PPAR alpha and gamma agonist muraglitazar Toxicol Sci 98 2007 258
20. E. Mylona, I. Giannopoulou, K. Diamantopoulou Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: association with differentiation, proliferation and clinical outcome Eur J Surg Oncol 35 2009 197
21. M. Ricote, A.C. Li, T.M. Willson The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79
22. M. Ricote, C.K. Glass PPARs and molecular mechanisms of transrepression Biochim Biophys Acta 1771 2007 926
23. C. Lodillinsky, V. Rodriguez, L. Vauthay Novel invasive orthotopic bladder cancer model with high cathepsin B activity resembling human bladder cancer J Urol 182 2009 749
24. G. Sauter, F. Algaba, M.B. Amin Tumours of the urinary system J.I. Epstein, J.N. Eble, I. Sesterhenn, World Health Organization Classification of Tumours Pathology and Genetics: Tumours of the Urinary System and Male Genital Organs 2004 IARC Press Lyon 89 157
25. C. Lodillinsky, Y. Langle, A. Guionet Bacillus Calmette Guerin induces fibroblast activation both directly and through macrophages in a mouse bladder cancer model PLoS One 5 2010 e13571
26. A.M. Eijan, I. Piccardo, M.D. Riveros Nitric oxide in patients with transitional bladder cancer J Surg Oncol 81 2002 203
27. Y.K. Chen, L.M. Lin Immunohistochemical expression of inducible nitric oxide synthase in DMBA-induced hamster buccal pouch carcinogenesis Oral Oncol 36 2000 221
28. K. Inoue, Y. Kawahito, Y. Tsubouchi Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists Biochem Biophys Res Commun 287 2001 727
29. C. Lodillinsky, M.S. Umerez, M.A. Jasnis Bacillus Calmette-Guerin induces the expression of peroxisome proliferator-activated receptor gamma in bladder cancer cells Int J Mol Med 17 2006 269
30. V. Alvarez, C. Lodillinsky, S. Umerez Inhibition of bacillus Calmette-Guerin-induced nitric oxide in bladder tumor cells may improve BCG treatment Int J Mol Med 16 2005 565